APA (7th ed.) Citation

Märten, A., Schmidt, J., Ose, J., Harig, S., Abel, U., Münter, M., . . . Büchler, M. W. (2009). A randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2. BMC cancer, 9, . https://doi.org/10.1186/1471-2407-9-160

Chicago Style (17th ed.) Citation

Märten, Angela, et al. "A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation Alone Regarding Event-free Survival - CapRI-2." BMC Cancer 9 (2009). https://doi.org/10.1186/1471-2407-9-160.

MLA (9th ed.) Citation

Märten, Angela, et al. "A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation Alone Regarding Event-free Survival - CapRI-2." BMC Cancer, vol. 9, 2009, https://doi.org/10.1186/1471-2407-9-160.